Disaster Lit: Resource Guide for Disaster Medicine and Public Health This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluating and Reporting Persons for Coronavirus Disease 2019 (COVID-19)
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/27/2020. This web page, updated on April 27, 2020, provides interim guidance for healthcare professionals regarding COVID-19 in two sections: Criteria to Guide Evaluation and Laboratory Testing for COVID-19; and Recommendations for Reporting, Testing, and Specimen Collection. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Impact of the COVID-19 Pandemic on Family Planning and Ending Gender-based Violence, Female Genital Mutilation and Child Marriage
Source: United Nations Population Fund (UNFPA). Published: 4/27/2020. The United Nations Population Fund aims to achieve three world-changing results by 2030: Ending unmet need for family planning, ending gender-based violence including harmful practices such as female genital mutilation and child marriage, and ending all preventable maternal deaths. This seven-page analysis shows how the COVID-19 pandemic could critically undermine progress made toward achieving these goals. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: U-TOP ™ COVID-19 Detection Kit – SEASUN BIOMATERIAL
Source: U.S. Food and Drug Administration (FDA). Published: 4/27/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the U-TOP ™ COVID-19 Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 27, 2020. The U-TOP™ COVID-19 Detection Kit is authorized for use on using respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare pro vider. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

Coronavirus Disease (COVID-19) FAQs for Law Enforcement Agencies and Personnel
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/27/2020. This web page provides answers to frequently asked questions about COVID-19 for law enforcement agencies and personnel, including about testing and personal protective equipment (PPE). (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

National Service Resources to Support COVID-19 Contact Tracing
Source: Centers for Disease Control and Prevention (CDC). Published: 4/26/2020. This two-page document provides information about programs that can support the efforts of the Centers for Disease Control and Prevention (CDC) and state, tribal, local, and territorial public health agencies to expand capacity for contact tracing and other COVID-19 response needs. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 26, 2020 Category: International Medicine & Public Health Source Type: news

NAS Annual Meeting: Experts Discuss COVID-19 Pandemic and Science ’s Response
Source: National Academies of Sciences, Engineering, and Medicine. Published: 4/26/2020. From the National Academy of Sciences Annual Meeting on April 25-27, 2020, this one-hour, 50-minute recording presents a diverse panel that speaks to the whole experience on dealing with the COVID-19 pandemic —from U.S. to international; to the state of diagnostic, treatment, and vaccine development; and to the importance of communication. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 26, 2020 Category: International Medicine & Public Health Source Type: news

WHO R & D Blueprint: Novel Coronavirus WHO Working Group: Core Protocol for Therapeutics Against COVID-19
Source: World Health Organization (WHO). Published: 4/26/2020. This four-page document describes the World Health Organization's convening of a group of experts to design a clinical trial for an effective treatment against COVID-19 that could be implemented in several countries with similar methodology, and primary and secondary outcomes that could be comparable. The overall goal is a large international study designed to generate robust data to rapidly demonstrate which treatments are the most effective. The core protocol should provide simplified procedures to enable even hospitals that have been overloaded to participa...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 26, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: SARS-CoV-2 IgG assay - Abbott Laboratories Inc.
Source: U.S. Food and Drug Administration (FDA). Published: 4/26/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 IgG assay, which received an Emergency Use Authorization from the Food and Drug Administration on April 26, 2020. SARS-CoV-2 IgG assay can be ordered by a healthcare provider to detect if there has been an adaptive immune response to COVID-19, indicating a recent or prior infection. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 26, 2020 Category: International Medicine & Public Health Source Type: news

JHU COVID-19 Community Response Survey
Source: Johns Hopkins University, Bloomberg School of Public Health. Published: 4/25/2020. The goal of this toolkit is to provide a set of standardized quantitative and qualitative assessments to harmonize data collection efforts and facilitate comparisons of the impact of the novel coronavirus (COVID-19), and promote collaborations across research efforts. This is intended to be a dynamic resource that will evolve as the epidemic does. These modules were created with a broad sample in mind. The goal was to develop a set of modules that could be applied to multiple populations with some minor tweaks. They can be used cros...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 25, 2020 Category: International Medicine & Public Health Source Type: news

Information for Clinicians on Investigational Therapeutics for Patients with COVID-19
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/25/2020. This web page, updated on April 25, 2020, discusses how there are no Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present, clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. It provides links to National Institutes of Health guidance and information about clinical trials. (Text) (Source: Disaster Lit: Resource Guide for Dis...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 25, 2020 Category: International Medicine & Public Health Source Type: news

Federal Healthcare Resilience Task Force COVID-19: Considerations, Strategies, and Resources for Emergency Medical Services Crisis Standards of Care
Source: National Highway Traffic Safety Administration, Office of Emergency Medical Services (EMS). Published: 4/25/2020. This 27-page document provides an overview of general considerations, potential strategies, and existing resources that emergency medical services (EMS) agencies may use to inform changes to their operations and standards of care in response to the COVID-19 pandemic. The team that created this document is composed of subject matter experts from NHTSA Office of EMS, CDC, FEMA, USFA, US Army, USCG, and non-federal partners representing stakeholder groups and areas of expertise. (PDF) (Source: Disaster Li...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 25, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: VitalPatch Biosensor
Source: U.S. Food and Drug Administration (FDA). Published: 4/25/2020. This three-page fact sheet informs healthcare providers of the emergency use of the VitalPatch Biosensor when used in the hospital setting for remote monitoring and detection of changes in the QT interval of an electrocardiogram (ECG) in general care (not in the intensive care unit) patients who are 18 years of age or older and are undergoing treatment for COVID-19 drugs that can prolong QT intervals and may cause life threatening arrhythmias (e.g., hydroxychloroquine or chloroquine, especially when used in combination with azithromycin). Such remote m...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 25, 2020 Category: International Medicine & Public Health Source Type: news

Medical Operations Coordination Cells Toolkit: First Edition
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/24/2020. This 50-page document from the Health and Human Services/Federal Emergency Management Agency COVID-19 Healthcare Resilience Task Force offers flexible and modifiable guidance, developed by the U.S. government, aimed to assist regional, state, local, tribal, and territorial governments to ensure load-balancing across healthcare facilities and systems so that the highest possible level of care can be provided to each patient during the coronavirus disease 2019 (COVID-19) pa...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 24, 2020 Category: International Medicine & Public Health Source Type: news

Infection Prevention and Control for COVID-19: Interim Guidance for Home Care Settings
Source: Government of Canada. Published: 4/24/2020. This web page provides guidance specific to the COVID-19 pandemic for home care organizations and staff to prevent the transmission of COVID-19 in home care settings. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 24, 2020 Category: International Medicine & Public Health Source Type: news

Coronavirus 2019 (COVID-19) Support for State, Tribes, Localities, and Territories
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/24/2020. This web page, updated on April 24, 2020, provides information and resources about COVID-19 for state, local, territorial, and tribal health departments. Information topics are Evaluating PUIs Residential; Travel-Associated Exposures: Public health recommendations; Pandemic Preparedness: Preparing for a pandemic; Reporting a Confirmed Case: Reporting and specimen referral; Community-Related Exposures: Public health recommendations; and Keeping America Open: Resources to get and keep America open. (Text) (Sour...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 24, 2020 Category: International Medicine & Public Health Source Type: news